Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.
Cancer Control. 2018 Jan-Dec;25(1):1073274818789361. doi: 10.1177/1073274818789361.
Cancer Control. 2018.
PMID: 30032643
Free PMC article.
Review.